Periode bali modal bisnis Taysha Gene Therapies Inc (TSHA)

Simbol lan logo merek Taysha Gene Therapies Inc (TSHA)

The investment potential of Taysha Gene Therapies (TSHA) is based on the deep outsourcing of all stages of drug development and production to external contractors. The company's P/E range visualizes market expectations, with the indicator standing at -8.30. This model is confirmed by a total dependence on CMOs and CROs, while the current lack of pricing power is offset by the prospect of premium pricing upon FDA approval of the Rett syndrome therapy.

Taysha Gene Therapies (TSHA) - Pangali P/E saka 04.07.2022 nganti 18.11.2026

Rincian metrik komprehensif lan analitis Taysha Corp (TSHA)

Ringkesan analisis perusahaan:TSHA (Taysha Gene Therapies Inc)
Barang unggulan Taysha

The P/E ratio determines the market value of a single unit of profit, calculated as the ratio of the current share price to earnings per share. By analyzing the market P/E ratio of Taysha Gene Therapies (TSHA), an investor assesses the degree of overpayment for the business, which is critical for Taysha Gene Therapies (TSHA) due to the high cost of developing Rett syndrome therapy and the protection of intellectual property through patents.

Analisis perusahaan pesaing

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Rasio rega marang bathi uniQure NV|Pangali rega marang bathi MGTX (MeiraGTx PLC)|Koefisien rega marang bathi RGNX (regenxbio.com)|Solid Biosciences Inc. - Pangali rega marang bathi|Rasio rega marang bathi Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|Design Pharma - Rasio rega pasar marang bathi resik|RCKT (Rocket Pharmaceuticals Inc) - Koefisien rega marang bathi|4D Molecular Therapeutics (FDMT) - Pangali P/E|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi